These therapeutic effects were evidenced by improved Forced Expiratory Volume in one second (FEV1) and Peak Expiratory Flow (PEF) values and symptoms scores, reduced inhaled 2-agonist usage, number of peripheral eosinophils, and serum IL-5, IL-13, and IgE, with increased serum cortisol and IFN- (Fig
Politi et al
Jia L, Xiao L, Fu Y, et al
Tested by an "FDA Approved Laboratory" If a supplement claims to have been tested in an "FDA Approved" laboratory, don't believe it: The FDA does not approve laboratories
The company also said that the treatment showed clinically meaningful benefits across key cardiovascular risk factors, which include non-HDL cholesterol, systolic blood pressure and triglycerides
Eur J Gastroenterol Hepatol 2000